Rebleeding rate and risk factors in nonsteroidal anti-inflammatory drug-induced enteropathy.

Junseok ParkSeong-Ran JeonJin-Oh KimHyun Gun KimTae Hee LeeJun-Hyung ChoBong Min KoJoon Seong LeeMoon Sung Lee

Published in: Journal of digestive diseases (2018)

Approximately one-fifth of patients with NSAIDs-induced enteropathy showed rebleeding within 2 years. A careful long-term follow-up should be offered to elderly patients with NSAIDs-induced enteropathy who need continuous NSAID treatment without the additional use of mucoprotective medications.

Keyphrases

drug induced
liver injury
risk factors
high glucose
diabetic rats
anti inflammatory
endothelial cells
adverse drug